Perth-headquartered global bio-nanotech company pSivida Ltd has announced results of trials by Bausch & Lomb to evaluate pSivida Ltd's RetisertTM implant for the treatment of diabetes related eye damage.

Perth-headquartered global bio-nanotech company pSivida Ltd has announced results of trials by Bausch & Lomb to evaluate pSivida Ltd's RetisertTM implant for the treatment of diabetes related eye damage.